M&A Deal Summary |
|
---|---|
Date | 2025-03-10 |
Target | Pathline |
Sector | Life Science |
Buyer(s) | NeoGenomics |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2001 |
Sector | Life Science |
Employees | 2,100 |
Revenue | 592M USD (2023) |
NeoGenomics is a clinical laboratory that specializes in cancer genetics diagnostic testing. The company’s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. NeoGenomics was founded in 2001 and is based in Fort Myers, Florida.
DEAL STATS | # |
---|---|
Overall | 7 of 7 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 6 of 6 |
State (New Jersey) | 1 of 1 |
Country (United States) | 5 of 5 |
Year (2025) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-01 |
Delf
Wirral, United Kingdom Delf is a United Kingdom-based manufacturer and supplier of animal hygiene and industrial cleaning products. Delf offers a wide range of animal hygiene and specialty chemical products. Delf is a select member of the Iodine Registration Group (IRG), allowing it to supply Article 95 PVP-iodine and iodine-based biocidal products to the UK and European Union animal hygiene markets. Delf was founded in 1928 and is based in Wirral, United Kingdom. |
Buy | - |